PMGC Holdings (ELAB) Short-term Investments (2024 - 2026)
PMGC Holdings (ELAB) posted Short-term Investments of $733405.0 for Q1 2026, up 28.21% sequentially from $572054.0 in Q4 2025, and up 31.58% YoY from $557375.0 in Q1 2025.
PMGC Holdings (ELAB) Short-term Investments (2024 - 2026) Analysis & Trends
PMGC Holdings has reported Short-term Investments for 3 years, with the latest figure at $733405.0 in Q1 2026.
- Quarterly Short-term Investments rose 31.58% year-over-year to $733405.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $733405.0 (up 31.58% YoY) and the FY2025 annual result came in at $572054.0, up 54694.44% from the prior year.
- Short-term Investments grew to $733405.0 in Q1 2026 per ELAB's latest filing, from $572054.0 in the prior quarter.
- Over five years, Short-term Investments peaked at $804070.0 in Q3 2025 and troughed at $1044.0 in Q4 2024.
- A 3-year average of $548797.7 and a median of $598446.0 in 2025 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2025 and 2026: Short-term Investments jumped 54694.44% in 2025, then jumped 31.58% in 2026.
- Over 3 years, Short-term Investments stood at $1044.0 in 2024, then surged by 54694.44% to $572054.0 in 2025, then increased by 28.21% to $733405.0 in 2026.
- According to Business Quant data, Short-term Investments over the past three periods registered $733405.0, $572054.0, and $804070.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | PMGC Holdings | 31.22 Mn | 12.43 Mn | 385,691.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 733,405.00 |
| Dec 31, 2025 | 572,054.00 |
| Sep 30, 2025 | 804,070.00 |
| Jun 30, 2025 | 624,838.00 |
| Mar 31, 2025 | 557,375.00 |
| Dec 31, 2024 | 1,044.00 |